Literature DB >> 17963590

Characterization of cholera outbreak isolates from Namibia, December 2006 to February 2007.

A M Smith1, K H Keddy, L De Wee.   

Abstract

We report on the first recorded outbreak of cholera in Namibia. From December 2006 to February 2007, more than 250 cases of cholera were reported from the Omusati and Kunene provinces of Namibia. However, only nine bacterial isolates were obtainable for analysis. Isolates were all identified as Vibrio cholerae O1 serotype Inaba biotype El Tor. All isolates were susceptible to ampicillin, augmentin, chloramphenicol, nalidixic acid, ciprofloxacin, tetracycline, kanamycin, imipenem, ceftriaxone and ceftazidime; and they all showed resistance to trimethoprim, sulfamethoxazole and streptomycin. Pulsed-field gel electrophoresis analysis of bacteria incorporating either SfiI or NotI digestion revealed an identical fingerprint pattern for all isolates. These data together with results indicating identical antimicrobial susceptibility profiles for all isolates determined that the outbreak was caused by a single strain of V. cholerae.

Entities:  

Mesh:

Year:  2007        PMID: 17963590      PMCID: PMC2870929          DOI: 10.1017/S0950268807009685

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  5 in total

1.  Cholera: a continuous epidemic in Africa.

Authors:  A Naidoo; K Patric
Journal:  J R Soc Promot Health       Date:  2002-06

2.  Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa.

Authors:  A M Smith; K P Klugman; T J Coffey; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction.

Authors:  S P Keasler; R H Hall
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

4.  Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae.

Authors:  K L F Cooper; C K Y Luey; M Bird; J Terajima; G B Nair; K M Kam; E Arakawa; A Safa; D T Cheung; C P Law; H Watanabe; K Kubota; B Swaminathan; E M Ribot
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

Review 5.  Cholera.

Authors:  David A Sack; R Bradley Sack; G Balakrish Nair; A K Siddique
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

  5 in total
  6 in total

Review 1.  Recurrent cholera epidemics in Africa: which way forward? A literature review.

Authors:  Abraham Ajayi; Stella I Smith
Journal:  Infection       Date:  2018-08-06       Impact factor: 3.553

Review 2.  Review of molecular subtyping methodologies used to investigate outbreaks due to multidrug-resistant enteric bacterial pathogens in sub-Saharan Africa.

Authors:  Anthony M Smith
Journal:  Afr J Lab Med       Date:  2019-03-14

3.  Comparative Characterization of Vibrio cholerae O1 from Five Sub-Saharan African Countries Using Various Phenotypic and Genotypic Techniques.

Authors:  Anthony M Smith; Berthe-Marie Njanpop-Lafourcade; Martin A Mengel; Bradford D Gessner; Delphine Sauvageot; Bawimodom Bidjada; Berthe N Miwanda; Diallo M Saliou; Adèle Kacou N'Douba; José P Langa; Husna Ismail; Nomsa Tau; Arvinda Sooka; Karen H Keddy
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

4.  High case fatality cholera outbreak in Western Kenya, August 2010.

Authors:  Dickens Onyango; Shirley Karambu; Ahmed Abade; Samuel Amwayi; Jared Omolo
Journal:  Pan Afr Med J       Date:  2013-07-24

Review 5.  Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa.

Authors:  Charles A Osunla; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2017-10-07       Impact factor: 3.390

Review 6.  Antimicrobial resistance of Vibrio cholerae from sub-Saharan Africa: A systematic review.

Authors:  Yahaya Mohammed; Aaron O Aboderin; Iruka N Okeke; Adebola T Olayinka
Journal:  Afr J Lab Med       Date:  2018-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.